catechin has been researched along with Liver Diseases in 42 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 22 (52.38) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (14.29) | 29.6817 |
2010's | 8 (19.05) | 24.3611 |
2020's | 6 (14.29) | 2.80 |
Authors | Studies |
---|---|
Cui, Q; Du, X; Jiang, T; Lai, B; Liu, J; Wang, N; Xiao, L; Xie, X; Yao, Q; Zhao, Z | 1 |
Jian, S; Li, L; Li, W; Li, Y; Shi, F; Song, X; Tang, H; Wang, Y; Ye, G; Yin, Z; Zhao, L; Zhao, X; Zou, Y | 1 |
Chen, D; Chen, J; Chen, W; Gu, K; Lai, X; Tan, L; Tang, D; Tang, Q; Wu, A; Yang, C | 1 |
Gao, Q; Granato, D; Hu, L; Kan, Z; Li, X; Peng, CY; Qian, F; Wang, D; Wang, T; Wang, Y | 1 |
Bao, S; Cao, Y; Hou, H; Yang, W | 1 |
Guo, H; Hao, S; He, R; Li, L; Li, Y; Shi, F; Song, X; Tang, H; Yan, Q; Ye, G; Zhao, L; Zou, Y | 1 |
Hirao, H; Jobara, K; Kadono, K; Kaido, T; Kawasoe, J; Miyauchi, T; Okajima, H; Terajima, H; Uchida, Y; Ueda, S; Uemoto, S; Watanabe, T | 1 |
Bak, MJ; Ho, CT; Jeong, WS; Jun, M; Kong, AN; Truong, VL | 1 |
Bak, J; Chung, HY; Je, NK; Moon, JO; Yokozawa, T; Yoon, S | 1 |
Afzal, M; Al-Bloushi, S; Mousa, SA; Safer, AM | 1 |
Antoniadis, N; Giakoustidis, AE; Giakoustidis, DE; Iliadis, S; Kaldrimidou, E; Koliakou, K; Kontos, N; Papageorgiou, G; Papanikolaou, V; Takoudas, D | 1 |
Arora, SK; Bharrhan, S; Chopra, K; Rishi, P; Toor, JS | 1 |
Ravindranath, MH; Ravindranath, NH | 1 |
Breig, L; Henrich, D; Lehnert, M; Marzi, I; Relja, B; Schneider, H; Töttel, E | 1 |
Noh, JS; Park, CH; Yokozawa, T | 1 |
Kalender, S; Kalender, Y; Yel, M | 1 |
Hammerschmidt, D | 1 |
El-Beshbishy, HA | 1 |
Athukorala, Y; Cho, JK; Choi, KD; Fukushima, M; Han, KH; Jeon, YJ; Kim, CJ; Lee, CH; Sekikawa, M | 1 |
Mead, MN | 1 |
Jávor, T; Pár, A | 1 |
Machalke, K; Müller, B | 1 |
Kovách, G; Salamon, F | 1 |
Kakumu, S; Kuriki, J; Murakami, H | 1 |
Ikeda, Y; Imai, E; Ito, K; Nose, T; Sato, I; Tajima, S; Takebe, H | 1 |
Schomerus, H | 1 |
Cornides, A; Fehér, J; Gógl, A; Pollák, Z; Sréter, L; Toncsev, H; Vereckei, A | 1 |
Beck, P; Boda, Z; Dalmi, L; Misz, M; Pfliegler, G; Weisz, G | 1 |
Awata, N; Midorikawa, T; Miura, S | 1 |
Siegers, CP | 1 |
Egger, G | 1 |
Hennings, G | 1 |
Leube, G; Sondern, W | 1 |
Ito, K; Nishimura, N; Tajima, S | 1 |
Adamska-Dyniewska, H; Dziekański, S; Jabłkowski, M | 1 |
Perrissoud, D | 1 |
Eremeeva, EP; Kamaeva, NG; Kodrian, AA; Semendiaeva, ME | 1 |
Ausheva, LKh; Bendikov, EA; Blok, IuE; Dzhalalov, KD; Loginov, AS | 1 |
Dumont, JM; Maignan, MF; Perrissoud, D | 1 |
Kostova, N; Krŭstev, Z; Lukanov, L; Maleev, A; Tsvetkova, V | 1 |
Gajdos, A; Gajdos-Török, M; Horn, R | 1 |
2 review(s) available for catechin and Liver Diseases
Article | Year |
---|---|
[Liver-protective substances, dietary treatment and cures in the treatment of hepatic diseases (author's transl)].
Topics: Animals; Bed Rest; Catechin; Dietary Proteins; Drug Evaluation; Energy Intake; Hepatic Encephalopathy; Humans; Liver Diseases; Physical Exertion; Silymarin | 1978 |
[On the molecular mechanism of action of (+)-cyanidanol-3 (author's transl)].
Topics: Animals; Benzopyrans; Catechin; Chemical and Drug Induced Liver Injury; Galactosamine; Lipid Peroxides; Liver; Liver Diseases; Membranes; Phalloidine | 1979 |
6 trial(s) available for catechin and Liver Diseases
Article | Year |
---|---|
(+)-cyanidanol-3.
Topics: Acute Disease; Benzopyrans; Catechin; Clinical Trials as Topic; Flavonoids; Hepatitis B; Humans; Liver Diseases | 1982 |
[Study of therapy in chronic liver diseases. Double-blind study with cianidanol].
Topics: Adult; Aged; Benzopyrans; Catechin; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Female; gamma-Glutamyltransferase; Humans; L-Lactate Dehydrogenase; Liver Diseases; Male; Middle Aged | 1982 |
[A contribution as to the effect of (+)-Cyanidanol-3 in chronic liver disease (author's transl)].
Topics: Benzopyrans; Catechin; Chronic Disease; Dose-Response Relationship, Drug; Humans; Liver Diseases | 1978 |
[Treatment of patients with disorders of the biotransformation function of the liver with (+)-cyanidanol-3].
Topics: Adult; Biotransformation; Catechin; Clinical Trials as Topic; Humans; Liver; Liver Diseases; Middle Aged | 1987 |
The development of cianidanol and 3-palmitoyl-(+)-catechin as drugs for the treatment of liver diseases.
Topics: Animals; Benzopyrans; Catechin; Clinical Trials as Topic; Dogs; Drug Evaluation, Preclinical; Hepatitis, Viral, Human; Humans; Liver Diseases; Papio; Rabbits; Rats; Tissue Distribution | 1986 |
[Catergen in the treatment of chronic liver diseases].
Topics: Catechin; Chronic Disease; Clinical Trials as Topic; Humans; Liver; Liver Diseases | 1986 |
34 other study(ies) available for catechin and Liver Diseases
Article | Year |
---|---|
Procyanidin B2 Attenuates Nicotine-Induced Hepatocyte Pyroptosis through a PPARγ-Dependent Mechanism.
Topics: Animals; Biflavonoids; Catechin; Hepatocytes; Inflammasomes; Interleukin-18; Liver Diseases; Mice; Nicotine; NLR Family, Pyrin Domain-Containing 3 Protein; PPAR gamma; Proanthocyanidins; Pyroptosis | 2022 |
Epigallocatechin-3-gallate ameliorates liver injury secondary to Pseudomonas aeruginosa pneumonia.
Topics: Alanine Transaminase; Animals; Anti-Bacterial Agents; Aspartate Aminotransferases; Catechin; Cytokines; Interleukin-6; Liver; Liver Diseases; Mice; Myeloid Differentiation Factor 88; NF-kappa B; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2022 |
Epigallocatechin-3-Gallate Alleviates Liver Oxidative Damage Caused by Iron Overload in Mice through Inhibiting Ferroptosis.
Topics: Animals; Antioxidants; Catechin; Ferroptosis; Iron Overload; Liver Diseases; Mice; Oxidative Stress | 2023 |
Green tea polyphenols and epigallocatechin-3-gallate protect against perfluorodecanoic acid induced liver damage and inflammation in mice by inhibiting NLRP3 inflammasome activation.
Topics: Animals; Antioxidants; Catechin; Decanoic Acids; Disease Models, Animal; Fluorocarbons; Inflammasomes; Inflammation; Liver Diseases; Male; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Polyphenols; Tea | 2020 |
Epigallocatechin Gallate Suppresses Inflammatory Responses by Inhibiting Toll-like Receptor 4 Signaling and Alleviates Insulin Resistance in the Livers of High-fat-diet Rats.
Topics: Animals; Anti-Inflammatory Agents; Catechin; Diet, High-Fat; Inflammation; Insulin Resistance; Liver; Liver Diseases; Phytotherapy; Rats, Sprague-Dawley; Signal Transduction; Tea; Toll-Like Receptor 4 | 2020 |
Epigallocatechin-3-gallate reduces liver and immune system damage in Acinetobacter baumannii-loaded mice with restraint stress.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Antioxidants; Catechin; Disease Models, Animal; Female; Immune System; Inflammation; Liver Diseases; Male; Mice; Mice, Inbred ICR; Oxidative Stress | 2021 |
Preventive Effect of Antioxidative Nutrient-Rich Enteral Diet Against Liver Ischemia and Reperfusion Injury.
Topics: Alanine Transaminase; Animals; Antioxidants; Ascorbic Acid; Aspartate Aminotransferases; Catechin; Diet; Digestive System Surgical Procedures; Enteral Nutrition; Food, Fortified; Ischemia; Liver; Liver Diseases; Male; Malondialdehyde; Mice, Inbred C57BL; Oxidative Stress; Plant Extracts; Proanthocyanidins; Reperfusion Injury; Superoxide Dismutase; Vitamin E | 2019 |
Antioxidant defense and hepatoprotection by procyanidins from almond (Prunus amygdalus) skins.
Topics: Animals; Antioxidant Response Elements; Antioxidants; Biflavonoids; Catalase; Catechin; Glutathione Peroxidase; Hep G2 Cells; Humans; Liver; Liver Diseases; Male; Mice; Mice, Inbred BALB C; NF-E2-Related Factor 2; Plant Extracts; Proanthocyanidins; Protective Agents; Prunus; Seeds; Superoxide Dismutase | 2014 |
Oligonol Ameliorates CCl₄-Induced Liver Injury in Rats via the NF-Kappa B and MAPK Signaling Pathways.
Topics: Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Biphenyl Compounds; Carbon Tetrachloride; Catechin; Cell Nucleus; Cyclooxygenase 2; Enzyme Activation; Ferrous Compounds; Gene Expression Regulation; Hep G2 Cells; Humans; Hydrogen Peroxide; Interleukin-1beta; Lipid Peroxidation; Liver; Liver Diseases; Malondialdehyde; MAP Kinase Signaling System; NF-kappa B; Nitric Oxide Synthase Type II; Phenols; Picrates; Protein Transport; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; tert-Butylhydroperoxide; Tumor Necrosis Factor-alpha | 2016 |
Green tea modulates reserpine toxicity in animal models.
Topics: Administration, Oral; Alanine Transaminase; Animals; Aspartate Aminotransferases; Catechin; Cholesterol, LDL; Dopamine Plasma Membrane Transport Proteins; Drug Administration Schedule; Drug Therapy, Combination; Endoplasmic Reticulum; Injections, Intraperitoneal; Liver; Liver Diseases; Microscopy, Electron, Transmission; Mitochondria; Molecular Structure; Organelles; Rats; Rats, Sprague-Dawley; Reserpine; Tea; Thiobarbituric Acid Reactive Substances; Transaminases | 2009 |
Attenuation of liver ischemia/reperfusion induced apoptosis by epigallocatechin-3-gallate via down-regulation of NF-kappaB and c-Jun expression.
Topics: Alanine Transaminase; Animals; Apoptosis; Aspartate Aminotransferases; Catechin; Down-Regulation; Immunohistochemistry; In Situ Nick-End Labeling; Ischemia; Liver Diseases; Malondialdehyde; NF-kappa B; Peroxidase; Proto-Oncogene Proteins c-jun; Rats; Rats, Wistar; Reperfusion Injury | 2010 |
Down-regulation of NF-κB signalling by polyphenolic compounds prevents endotoxin-induced liver injury in a rat model.
Topics: Animals; Antioxidants; Catechin; Disease Models, Animal; Endotoxins; Female; Humans; Liver Diseases; NF-kappa B; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidative Stress; Polyphenols; Quercetin; Rats; Rats, Wistar; Sepsis; Signal Transduction; Tumor Necrosis Factor-alpha | 2012 |
Green tea catechins suppress NF-κB-mediated inflammatory responses: relevance to nutritional management of inflammation.
Topics: Animals; Anti-Inflammatory Agents; Camellia sinensis; Catechin; Female; Liver Diseases; Phytotherapy; Reperfusion Injury | 2011 |
Effects of green tea catechins on the pro-inflammatory response after haemorrhage/resuscitation in rats.
Topics: Alanine Transaminase; Analysis of Variance; Animals; Anti-Inflammatory Agents; Camellia sinensis; Catechin; Enzyme-Linked Immunosorbent Assay; Female; Hemorrhage; Intercellular Adhesion Molecule-1; Interleukin-6; Liver; Liver Diseases; Necrosis; Neutrophil Infiltration; NF-kappa B; Phytotherapy; Plant Extracts; Rats; Reperfusion Injury; Resuscitation | 2011 |
Treatment with oligonol, a low-molecular polyphenol derived from lychee fruit, attenuates diabetes-induced hepatic damage through regulation of oxidative stress and lipid metabolism.
Topics: Animals; Biomarkers; Catechin; Cholesterol; Cyclooxygenase 2; Diabetes Complications; Fruit; Gene Expression Regulation; Lipid Metabolism; Litchi; Liver; Liver Diseases; Lysine; Mice; Nitric Oxide Synthase Type II; Organ Size; Oxidative Stress; Phenols; PPAR alpha; Receptor for Advanced Glycation End Products; Receptors, Immunologic; RNA, Messenger; Sterol Regulatory Element Binding Protein 1; Sterol Regulatory Element Binding Protein 2; Transcription Factor RelA; Triglycerides | 2011 |
Doxorubicin hepatotoxicity and hepatic free radical metabolism in rats. The effects of vitamin E and catechin.
Topics: Animals; Catechin; Chemical and Drug Induced Liver Injury; Doxorubicin; Free Radicals; Liver; Liver Diseases; Male; Rats; Rats, Sprague-Dawley; Vitamin E | 2005 |
About the cover illustration: Thea sinensis - the common tea plant.
Topics: Anticarcinogenic Agents; Camellia sinensis; Catechin; Humans; Liver Diseases; Phytotherapy | 2005 |
Hepatoprotective effect of green tea (Camellia sinensis) extract against tamoxifen-induced liver injury in rats.
Topics: Animals; Antineoplastic Agents, Hormonal; Antioxidants; Camellia sinensis; Catechin; Chemical and Drug Induced Liver Injury; Female; Liver; Liver Diseases; Plant Extracts; Random Allocation; Rats; Tamoxifen; Tea; Thiobarbituric Acid Reactive Substances | 2005 |
A water extract of Artemisia capillaris prevents 2,2'-azobis(2-amidinopropane) dihydrochloride-induced liver damage in rats.
Topics: Alanine Transaminase; Amidines; Animals; Artemisia; Aspartate Aminotransferases; Catechin; Chemical and Drug Induced Liver Injury; Chromatography, High Pressure Liquid; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Liver; Liver Diseases; Male; Oxidants; Oxidative Stress; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Thiobarbituric Acid Reactive Substances; Water | 2006 |
Temperance in green tea.
Topics: Animals; Antioxidants; Camellia sinensis; Catechin; Chemical and Drug Induced Liver Injury; Dietary Supplements; Humans; Liver Diseases; Plant Extracts; Tea | 2007 |
Alternatives in hepatoprotection: cytoprotection--influences on mono-oxidase system--free radical scavengers (a review).
Topics: Animals; Antioxidants; Catechin; Chemical and Drug Induced Liver Injury; Enzyme Induction; Free Radicals; Gastric Mucosa; Humans; Intestinal Mucosa; Liver; Liver Diseases; Mixed Function Oxygenases; Oxidoreductases; Prednisolone; Superoxides | 1984 |
Effects of (+)-cyanidanol-3 on chronic liver injury.
Topics: Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Benzopyrans; Catechin; Chronic Disease; Diabetes Complications; Fatty Liver; Female; gamma-Glutamyltransferase; Humans; Liver; Liver Diseases; Liver Diseases, Alcoholic; Liver Function Tests; Male; Middle Aged | 1984 |
Activation of suppressor function of human peripheral blood T cells by (+)cyanidanol-3: its application to chronic active liver diseases.
Topics: Benzopyrans; Catechin; Cells, Cultured; Concanavalin A; Dose-Response Relationship, Drug; Humans; Immunoglobulin M; Immunoglobulins; Liver Diseases; Lymphocyte Activation; Pokeweed Mitogens; T-Lymphocytes; T-Lymphocytes, Regulatory | 1983 |
[Effects of cianidanol (KB-53) on experimental liver injury in mice--histopathological, histochemical and enzyme-histochemical studies].
Topics: 1-Naphthylisothiocyanate; Alkaline Phosphatase; Animals; Benzopyrans; Carbon Tetrachloride; Catechin; Chemical and Drug Induced Liver Injury; Flavonoids; Glucose-6-Phosphatase; Histocytochemistry; Liver; Liver Diseases; Male; Mice; Mice, Inbred ICR | 1983 |
[What is certain in the therapy of hepatocellular diseases with cyanidanol?].
Topics: Benzopyrans; Catechin; Chronic Disease; Hepatitis; Hepatitis, Viral, Human; Humans; Liver Diseases | 1983 |
Experimental models for the study of hepatoprotection.
Topics: Animals; Catechin; Chemical and Drug Induced Liver Injury; Chronic Disease; Enzymes; Granulocytes; Hepatitis, Chronic; Humans; Liver; Liver Diseases; Lysosomes; Malondialdehyde; Mice; Quinolines | 1984 |
Effect of Catergen [(+)cyanidanol-3] on some haemostatic parameters in chronic liver diseases.
Topics: Adult; Aged; Blood Coagulation Tests; Catechin; Clinical Enzyme Tests; Fatty Liver; Female; Hemostasis; Hepatitis, Chronic; Humans; Liver Cirrhosis; Liver Diseases; Male; Middle Aged; Time Factors | 1984 |
[Synthesis of (3-2H)-and (3-3H)-cianidanol].
Topics: Benzopyrans; Catechin; Deuterium; Humans; Liver Diseases; Tritium | 1983 |
[Effect of silymarin and (+)-cyanidanol-3 on hexachlorobenzene(HCB)-induced porphyria in rats].
Topics: Animals; Benzopyrans; Catechin; Chlorobenzenes; Disease Models, Animal; Flavonoids; Hexachlorobenzene; Liver Diseases; Porphyrias; Rats; Research Design; Silymarin | 1982 |
Suppression of delayed-type hypersensitivity mediated by macrophage-like cells in mice with experimental liver injury.
Topics: 1-Naphthylisothiocyanate; Animals; Carbon Tetrachloride; Catechin; Chemical and Drug Induced Liver Injury; Dinoprostone; Drug Hypersensitivity; Hypersensitivity, Delayed; Indomethacin; Liver Diseases; Macrophages; Male; Mice; Mice, Inbred BALB C; Picryl Chloride; Prostaglandins E; Spleen; Superoxides; T-Lymphocytes, Regulatory | 1985 |
[Treatment of chronic diseases of the liver with catergen].
Topics: Adolescent; Adult; Aged; Benzopyrans; Catechin; Chronic Disease; Fatty Liver, Alcoholic; Female; Hepatitis, Chronic; Humans; Lipid Peroxides; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Cirrhosis, Biliary; Liver Diseases; Male; Middle Aged; Phosphatidylcholines | 1986 |
Antinecrotic effect of 3-palmitoyl-(+)-catechin against liver damage induced by galactosamine or ethanol in the rat.
Topics: Animals; Benzopyrans; Catechin; Chemical and Drug Induced Liver Injury; Ethanol; Galactosamine; Hypoxia; Liver Diseases; Male; Necrosis; Rats; Rats, Inbred Strains | 1985 |
[Clinical study of the effect of the administration of cathergen preparation in patients with chronic hepatic lesions].
Topics: Adult; Aged; Benzopyrans; Catechin; Chronic Disease; Fatty Liver; Female; Hepatitis; Hepatitis, Chronic; Humans; Liver Cirrhosis; Liver Diseases; Male; Middle Aged | 1985 |
[Therapeutic effect of the (+)-catechin on biochemical disorders of the liver in the ethanol intoxicated rat].
Topics: Adenosine Triphosphate; Alcoholic Intoxication; Animals; Catechin; Female; Humans; Lipids; Liver; Liver Diseases; NAD; Rats; Rats, Inbred Strains | 1972 |